Two people with severe depression that didn’t respond to other treatments felt better and had fewer thoughts of suicide right after they stopped using a nasal spray called esketamine—even though they felt worse while using it.
Claim Language
Language Strength
association
Uses association language (linked to, correlated with)
The claim uses 'was associated with', which indicates a statistical or observational link rather than proof of cause or direct effect. This phrasing avoids claiming that discontinuation caused the improvement, only that the two events occurred together.
Context Details
Domain
medicine
Population
human
Subject
Two patients with treatment-resistant depression
Action
was associated with
Target
rapid clinical improvement in depressive symptoms and reduction in suicidal ideation
Intervention Details
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Evidence from Studies
Supporting (1)
Paradoxical Depressive Response to Intranasal Esketamine in Treatment-Resistant Depression: A Case Series
Two people with severe depression got worse while taking a nasal spray called esketamine, but felt better right after they stopped taking it. This matches the claim that stopping the spray helped them.